DSL-201

N/A

Report date: 2026/03/31 15:15:34

Base Information

Drug NameDSL-201
Drug Alias NameDSL201DSL-201
ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNasolabial fold wrinklesGlabellar lines
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Xinghe Disai Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Xinghe Disai Biotechnology Co LtdSuzhou Xinghe Disai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNasolabial fold wrinklesGlabellar lines
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A